Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype
Histopathology · 2026
DOI: 10.1111/his.15531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Marco Grillini und 21 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Carcinoma, Histocompatibility Antigens Class I, Loss of Heterozygosity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS.
Abstract (Originalsprache)
Aims
This study aims to define and characterize human leukocyte antigen class I (HLA‐I) expression in a consecutive series of molecularly classified endometrial carcinomas (ECs), and to evaluate its association with clinicopathologic features, spatial cancer–immune phenotypes and patient prognosis, with a focus on the NSMP (no specific molecular profile) subtype. Methods and results HLA‐I expression was assessed by immunohistochemistry on whole tissue sections from 208 ECs, classified into POLE ‐mutated, MMR‐deficient (MMRd), p53‐abnormal (p53abn) and NSMP subtypes. Loss of HLA‐I was identified in 31% of cases and was associated with adverse features including high‐grade, aggressive histotypes, deep myometrial invasion, substantial lymphovascular space invasion (LVSI), extensive tumour necrosis and an ‘excluded’ immune phenotype. While HLA‐I loss showed no significant prognostic impact in POLE , MMRd or p53abn tumours, it significantly correlated with worse disease‐free survival in NSMP tumours ( P < 0.001). Multivariate analysis confirmed HLA‐I loss as an independent prognostic factor in early‐stage NSMP ECs, in addition to substantial LVSI, presence of lymph node metastases and spatial cancer–immune phenotypes. Integration of HLA‐I status improved the performance of predictive models over time.
Conclusions
HLA‐I loss defines a biologically aggressive subgroup within NSMP ECs and is associated with adverse clinicopathologic and immune features. Assessment of HLA‐I expression could refine risk stratification in NSMP ECs, a group traditionally lacking robust prognostic markers and may help identify patients who could benefit from intensified clinical surveillance and future immunomodulatory treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
- Department of Pharmacy and Biotechnology (FaBit), University of Bologna, Bologna, Italy.
- Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania.
ORCID-Profile: Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli, Dario de Biase, Thais Maloberti, Sara Coluccelli, Riccardo Ciudino, Caterina Ravaioli, Camelia Alexandra Coadǎ, Gloria Ravegnini, Anna Myriam Perrone, Pierandrea De Iaco, Claudio Zamagni, Benedetta Donati, Alessia Ciarrocchi, Sabrina Croce, Martin Köbel, Cheng-Han Lee, Giovanni Tallini, Antonio De Leo
Förderung
- Fondazione AIRC per la ricerca sul cancro ETS
Zitieren
APA
Grillini, M., Lenzi, J., Ceccarelli, C., de Biase, D., Maloberti, T., Coluccelli, S., Poppi, L., Ciudino, R., Ravaioli, C., Coadǎ, C. A., Ravegnini, G., Perrone, A. M., De Iaco, P., Rubino, D., Zamagni, C., Donati, B., Ciarrocchi, A., Croce, S., Köbel, M., …, & De Leo, A. (2026). Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype. Histopathology. https://doi.org/10.1111/his.15531
Vancouver
Grillini M, Lenzi J, Ceccarelli C, de Biase D, Maloberti T, Coluccelli S, et al. Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype. Histopathology. 2026. doi:10.1111/his.15531
BibTeX
@article{Grillini2026,
author = {Grillini, Marco and Lenzi, Jacopo and Ceccarelli, Claudio and de Biase, Dario and Maloberti, Thais and Coluccelli, Sara and Poppi, Laura and Ciudino, Riccardo and Ravaioli, Caterina and Coadǎ, Camelia Alexandra and Ravegnini, Gloria and Perrone, Anna Myriam and De Iaco, Pierandrea and Rubino, Daniela and Zamagni, Claudio and Donati, Benedetta and Ciarrocchi, Alessia and Croce, Sabrina and Köbel, Martin and Lee, Cheng-Han and Tallini, Giovanni and De Leo, Antonio},
title = {Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype},
journal = {Histopathology},
year = {2026},
doi = {10.1111/his.15531}
}
EUVIMED